| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 2.570 | 7.015 | 20.082 | 18.967 | 33.587 |
| Total Income - EUR | - | - | - | - | 0 | 2.574 | 7.426 | 21.027 | 19.856 | 34.152 |
| Total Expenses - EUR | - | - | - | - | 487 | 5.305 | 12.290 | 14.707 | 18.543 | 18.756 |
| Gross Profit/Loss - EUR | - | - | - | - | -487 | -2.731 | -4.863 | 6.320 | 1.313 | 15.395 |
| Net Profit/Loss - EUR | - | - | - | - | -487 | -2.803 | -5.074 | 5.725 | 575 | 12.529 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Novel Mushrooms S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 24.667 | 19.670 | 13.348 | 7.214 |
| Current Assets | - | - | - | - | 2 | 3.093 | 6.777 | 21.627 | 7.932 | 9.684 |
| Inventories | - | - | - | - | 0 | 2.259 | 3.508 | 5.414 | 5.670 | 3.853 |
| Receivables | - | - | - | - | 0 | 115 | 0 | 0 | 939 | 3.907 |
| Cash | - | - | - | - | 2 | 718 | 3.270 | 16.214 | 1.324 | 1.924 |
| Shareholders Funds | - | - | - | - | -445 | -3.240 | -8.241 | -2.541 | -1.958 | 10.581 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 448 | 6.332 | 38.094 | 42.699 | 22.556 | 6.091 |
| Income in Advance | - | - | - | - | 0 | 0 | 1.592 | 1.141 | 682 | 226 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Novel Mushrooms S.r.l.